Scientific Online Resource System

Scripta Scientifica Salutis Publicae

Patient–reported outcomes – an approach and application in amniotic membrane transplantation

Yana Manolova, Desislava Vankova, Christina Grupcheva

Abstract

Patient-reported outcomes (PROs) are a comparatively novel concept in medicine and in public health ser­vices evaluation. It relies on the fact that medical technologies are not able to give all the information about the treatment or a medical condition. Some essential data can be obtained only from the patient.

Herewith, the PROs approach is presented in relation to amniotic membrane transplantation (AMT) which is applied to patients who have been treated at Varna Specialized Eye Hospital for different severe anterior ocular surface diseases (AOSDs).

The aim of the study is to present the PROs approach and the created especially for the study Patient-Re­ported Outcome Measures (PROMs) tool. Further on, we aim to summarize, analyze and discuss the PROs-data of the study.

MATERIALS AND METHODS: The presented PROs study enrolls 306 hospitalized patients diagnosed in seven cohorts and suitable for AMT for a period of seven years (2010-2016). It is a part of a wider research project. Demographic data and disease-related characteristics were collected in addition to the PROMs ques­tionnaire. The PROMs instrument consists of 4 domains/questions, and the possible answers are arranged in ordinal scales. The first domain is Pain, and the possible answers are 5 (0 - none; 1 - sometimes low; 2 - always low; 3 - moderate to severe; 4 - always severe). The second domain is Photophobia, and the possible answers are 4 (0 - none; 1 - only at strong light; 2 - at daylight; 3 - at moderate light). The third domain is Se­cretion and the possible answers are 4 (0 - none; 1 - watery; 2 - mucous secretion; 3 - purulent discharge). The fourth domain is Hyperemia and the possible answers following the Efron grading scale are 5 (grade 0 - normal; grade 1 - trace; grade 2 - mild; grade 3 - moderate; grade 4 - severe).

RESULTS AND DISCUSSION: The AM treatment resulted in a significant reduction of the symptoms in all domains (p< 0.001). Regarding the Pain domain, in all the groups, over 60% of the patients report­ed improvement. More than 90% of the patients with the most severe conditions like keratitis reported im­provement. The reported and analyzed results indicate that AMT has a positive impact on all the PROs do­mains – Pain, Photophobia, Secretion and Hyper­emia, for every patient (p<0.001). This is a novel study for Bulgaria, which aims to measure the im­pact of AMT on PROs among a large number of pa­tients with severe AOSDs divided into seven cohorts for seven years. AMT proved to be a surgical method for treatment of chronic, recurrent AOSDs that im­prove patients’ subjective well-being.


Keywords

patient-reported outcomes and measures, amniotic membrane transplantation

Full Text


References

Nightingale F. Notes on hospitals [Internet]. London, Longman, Green, Longman, Roberts, and Green; 1863 [cited 2017 Feb 2]. 244 p.

FDA, 2009. Guidance for Industry. Patient- Reported Outcome Measures: Use in Medical Product Development to Support Label.

Donabedian A. Explorations in quality assessment and monitoring: the definition of quality and approaches to its assessment. Vol. 3. The methods and findings of quality assessment measurement and monitoring. Ann Arbor, MI: Health Administration Press; 1985.

Fraunfelder FT, Fraunfelder Jr FW, Chambers WA. Drug-Induced Ocular Side Effects: Clinical Ocular Toxicology. Elsevier Health Sciences; 2014. p .425.

Honda R, Toshida H, Suto C, Fujimaki T, Kimura T, Ohta T, et al. Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora. Infect Drug Resist. 2011;4:191–6. doi: 10.2147/IDR.S24250

Baguneid MS, Seifalian AM, Salacinski HJ, Murray D, Hamilton G, Walker MG. Tissue engineering of blood vessels. Br J Surg. 2006;93(3):282–90. doi: 10.1002/bjs.5256

Young CS, Abukawa H, Asrican R, Ravens M, Troulis MJ, Kaban LB, et al. Tissue-engineered hybrid tooth and bone. Tissue Eng. 2005;11(9– 10):1599–610. doi: 10.1089/ten.2005.11.1599

Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001;7(6):679–89. doi: 10.1089/107632701753337645

Walgenbach KJ, Voigt M, Riabikhin AW, Andree C, Schaefer DJ, Galla TJ, et al. Tissue engineering in plastic reconstructive surgery. Anat Rec. 2001;263(4):372–8. doi: 10.1002/ar.1117

Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19(3):348–52.

Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000 Mar;70(3):329–37. doi: 10.1006/exer.1999.0794

Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol. 2001;85(12):1455–63. doi: 10.1136/bjo.85.12.1455

Solomon A, Meller D, Prabhasawat P, John T, Espana EM, Steuhl K-P, et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology. 2002;109(4):694–703. doi: 10.1016/ S0161-6420(01)01032-6

Takano Y, Fukagawa K, Miyake-Kashima M, Tanaka M, Asano-Kato N, Dogru M, et al. Dramatic healing of an allergic corneal ulcer persistent for 6 months by amniotic membrane patching in a patient with atopic keratoconjunctivitis: a case report. Cornea. 2004;23(7):723–5.

Anderson DF, Prabhasawat P, Alfonso E, Tseng SC. Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea. 2001;20(4):354–61.

Meller D, Pires RT, Mack RJ, Figueiredo F, Heiligenhaus A, Park WC, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology. 2000;107(5):980–9; discussion 990. doi: 10.1016/S0161-6420(00)00024-5

Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol Chic Ill 1960. 1998;116(4):431–41. doi:10.1001/archopht.116.4.431

Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol. 1999;83(4):414–9. doi: 10.1136/bjo.83.4.414

Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122(1):38–52. doi: 10.1016/ S0002-9394(14)71962-2

LOP-Amniotic-Membrane-Transplantation.pdf [Internet]. [cited 2016 Jun 23]. Available from: http://ibi-iran.com/wp-content/uploads/2015/07/ LOP-Amniotic-Membrane-Transplantation.pdf

Stefaniu G, Chiotoroiu S, Secureanu F, Purcarea V, Zemba M. Use of amniotic membrane in bullous keratopathy palliative care. J Med Life. 2014;7(Spec Iss 2):88–91.

Tok OY, Tok L, Atay IM, Argun TC, Demirci N, Gunes A. Toxic keratopathy associated with abuse of topical anesthetics and amniotic membrane transplantation for treatment. Int J Ophthalmol. 2015;8(5):938–44. doi: 10.3980/j. issn.2222-3959.2015.05.15

Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20(4):408–13.

Thatte S. Amniotic membrane transplantation: An option for ocular surface disorders. Oman J Ophthalmol. 2011;4(2):67–72. doi: 10.4103/0974-620X.83656

Espana EM, Grueterich M, Sandoval H, Solomon A, Alfonso E, Karp CL, et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003;29(2):279–84. doi: 10.1016/ S0886-3350(02)01525-0

Liang W, Li R, Deng X. Comparison of the efficacy of pterygium resection combined with conjunctival autograft versus pterygium resection combined with amniotic membrane transplantation. Eye Sci. 2012;27(2):102–5.

Huang Y, Wang B, Ye Q. [Clinical study in combining application of mitomycin and amnion transplantation together with pterygium resection]. Yan Ke Xue Bao Eye Sci Yan Ke Xue Bao Bian Ji Bu. 2005;21(4):110–3, 123.

Cheng AMS, Zhao D, Chen R, Yin HY, Tighe S, Sheha H, et al. Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic Membrane. Ocul Surf. 2016;14(1):56–63. doi: 10.1016/j.jtos.2015.07.003




DOI: http://dx.doi.org/10.14748/sssp.v3i1.2052

Refbacks

About The Authors

Yana Manolova
Medical University of Varna

Department of Ophthalmology and Visual Science, Faculty of Medicine

Desislava Vankova
Medical University of Varna

Department of Social Medicine and Health Care Organization, Faculty of Public Health

Christina Grupcheva
Medical University of Varna

Department of Ophthalmology and Visual Science, Faculty of Medicine

Font Size


|